XML 34 R12.htm IDEA: XBRL DOCUMENT
v3.25.1

REVENUE RECOGNITION | 12 Months Ended
--- | ---
Dec. 31, 2024
REVENUE RECOGNITION |
REVENUE RECOGNITION | NOTE 4 – REVENUE RECOGNITION Products consist of the following:
| · | Antimony: includes antimony oxide, antimony metal, and antimony trisulfide
| · | Zeolite: includes coarse and fine zeolite crushed in various sizes
| · | Precious metals: includes unrefined and refined gold and silver
Sales by product for the years ended December 31, 2024 and 2023 were as follows:
|  | For the years ended |
|  | December 31, 2024 |  |  | December 31, 2023 |
Antimony product revenue |  | $ | 11,471,200 |  |  | $ | 5,904,480 |
Zeolite product revenue |  |  | 2,941,675 |  |  |  | 2,462,179 |
Precious metals product revenue |  |  | 525,087 |  |  |  | 326,496 |
TOTAL REVENUES |  | $ | 14,937,962 |  |  | $ | 8,693,155 |
The Company also received royalties related to a trademark and licensing agreement in its antimony business segment, which is recorded in “Trademark and licensing income” under the caption “Other Income (Expense)” in its Consolidated Statements Operations. The following is sales information by geographic area based on the location of customers for the years ended December 31, 2024 and 2023:
|  | For the years ended |
|  | December 31, 2024 |  |  | December 31, 2023 |
Domestic revenues |  | $ | 12,572,625 |  |  | $ | 6,854,740 |
Canada revenues |  |  | 1,996,710 |  |  |  | 1,838,415 |
Mexico revenues |  |  | 368,627 |  |  |  | - |
TOTAL REVENUES |  | $ | 14,937,962 |  |  | $ | 8,693,155 |
Sales to customers representing more than 10% of our total revenues during the years ended December 31, 2024 and 2023 were as follows:
|  | For the years ended |
|  | December 31, 2024 |  |  | December 31, 2023 |
Customer A revenue |  | $ | 4,389,735 |  |  | $ | 1,548,283 |
Customer B revenue |  |  | 1,998,589 |  |  |  | 1,451,950 |
Customer C revenue |  |  | - |  |  |  | 1,037,307 |
Total |  | $ | 6,388,324 |  |  | $ | 4,037,540 |
Total customer revenue as a % of total Company revenues |  |  | 43% |  |  |  | 46% |
Customer receivables representing more than 10% of our net accounts receivable balance as of December 31, 2024 and 2023 were as follows:
|  | For the years ended |
|  | December 31, 2024 |  |  | December 31, 2023 |
Customer A receivable |  | $ | 682,551 |  |  | $ | 194,007 |
Customer B receivable |  |  | - |  |  |  | 202,382 |
Total |  | $ | 682,551 |  |  | $ | 396,389 |
Total customer receivables as a % of Company net accounts receivable |  |  | 59% |  |  |  | 63% |
The Company’s trade accounts receivable balance related to contracts with customers was $1,156,564 at December 31, 2024 and $625,256 at December 31, 2023, which is net of an allowance for doubtful accounts related to trade accounts receivables of $10,165 and $271,212 at December 31, 2024 and December 31, 2023, respectively. The Company’s products do not involve any warranty agreements and product returns are not typical.

X
- References No definition available. + Details
Name: | uamy_RevenueRecognitionDisclosureTextBlock
Namespace Prefix: | uamy_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration